Skip to main content
PLOS One logoLink to PLOS One
. 2026 Mar 30;21(3):e0344012. doi: 10.1371/journal.pone.0344012

Evaluation of a training program for rheumatic heart disease screening integrated into the public health system in Uganda

Paul W Warren 1,2,*, Scott Wirth 3, Jafesi Pulle 4,5, Doreen Nakaagayi 4,5, Charles Oyoo Akia 6, Evelyn Ayaa 7, Michaela Pardo 8, Francis Odong 4, Ronald Ogwanh 4, John Omagino 4, Isaac Otim 4, Craig Sable 9, Alison Spaziani 9, Henry Okello Otto 7, David Watkins 8, Emmy Okello 4, Kristen Danforth 8, Andrea Beaton 1,2
Editor: Rano Mal Piryani10
PMCID: PMC13035113  PMID: 41911246

Abstract

Introduction

Echocardiography screening for rheumatic heart disease (RHD) has gained support as a public health approach, but scale up of RHD screening services is complex. We sought to evaluate the effectiveness of a novel training program to build non-expert competency for RHD echocardiography screening within the Uganda public health system and to describe the human and material resources required to support it.

Methods

Guided by a logic model, we evaluated the Accelerating Delivery of Rheumatic Heart Disease Prevention in Northern Uganda (ADUNU) Program, a novel RHD control program, 15 months after its implementation within the Ugandan public health care system.

Results

Sixty-one healthcare workers (HCW) across 10 public health facilities started in training under the program, of which 58 (95%) advanced past the initial stage of training and earned conditional certification to screen for RHD with ongoing remote and in-person feedback and oversight. Of these, 17 (29%) completed all stages of training and earned full certification to independently screen for RHD with no ongoing oversight. A total of 17,927 community members were screened through ADUNU during the program’s first 15 months. After receiving final certification, 14 HCWs (93%) continued to perform screening echocardiograms (≥20/month) at median follow-up of 8 months [IQR 8–10]. HCW sensitivity and specificity were 61% and 96%, respectively.

Conclusion

Development and deployment of a large scale RHD screening echocardiography training program within an existing public health system is feasible. Future program iterations are needed to improve HCW screening sensitivity and decrease the reliance on human resources.

Introduction

Echocardiography is a powerful tool for early rheumatic heart disease (RHD) detection [1–3]. While originally employed as epidemiological research, echocardiography screening for RHD has more recently gained support as a public health approach [4–6]. This shift resulted from a randomized controlled trial which found early diagnosis and initiation of secondary antibiotic prophylaxis significantly decreased the 2-year risk for RHD progression [7]. In 2023, the World Heart Federation (WHF) published updated guidance on echocardiographic screening for RHD in high-risk populations, and in 2024 the World Health Organization formally recommended countries implement screening, especially in high prevalence settings [1,8].

However, scale up of RHD screening services is complex, especially in resource-limited settings with low availability of subspecialty expertise and equipment [9]. Shifting the screening burden to a more readily available workforce through task-shifting presents an alternative solution. Training for task-shifting RHD screening has been proposed since at least 2015, but no standardized programs have emerged [10]. Most models have relied on training non-expert health care workers (often nurses), utilizing hand-held ultrasound machines [11–14], and performing simplified screening protocols to reduce time and complexity [15–17]. These approaches have shown acceptable sensitivity and specificity. However, most studies have involved a small number of non-expert providers, often in the context of an incentivized research study. With RHD screening now recommended as a public health approach, there is need for replicable training programs to support the scale-up of service provision [18].

In 2023, the Ugandan Ministry of Health and the Uganda Heart Institute (UHI) embarked on the deployment of an evidence based RHD control program, supported by the RHD Research Collaborative in Uganda (RRCU) as an implementing partner [19]. The Accelerating Delivery of Rheumatic Heart Disease Prevention in Northern Uganda (ADUNU) Program aims to find more cases of RHD by integrating RHD screening into the existing Ugandan public health system by offering screening at all community-level health center III (HCIII) facilities in participating districts [19].

At the end of the first year, we evaluated the effectiveness of the ADUNU training curriculum at building non-expert HCW competency in RHD echocardiography screening and HCW integration of screening into their clinical practice. To do so, we utilized a logic model to map the program’s resources, actions, outputs and outcomes [20,21], with a goal of understanding how this program should be modified to create a standardized training program that could be adopted globally.

Materials and methods

Evaluation timing

Fifteen months after the initiation of the ADUNU training curriculum, we utilized programmatic data to 1) describe the human resources, material resources, and activities that were input into the training program, 2) describe the outputs of the training program, and 3) evaluate the outcomes of the training program. Data sources included training team field notes, meeting notes, training logs and certifications, echocardiographic screening logs, and reports of image agreement between HCWs and experts who were providing remote support. Program data on the training program for RHD screening collected between May 2023 and August 2024 was utilized for the evaluation. Data was accessed for research purposes from 22/9/24–3/3/25.

Ethical approval

Programmatic data utilization for ADUNU is approved under the Uganda Heart Institute Institutional Review Board (UHIREC0008/UHIREC0021), the Ugandan National Council of Science and Technology (HS2470ES), and the Cincinnati Children’s Hospital Medical Center Institutional Review Board. No individually identifiable data was utilized for this evaluation and no individual consent was required. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Setting

Kitgum District, a largely rural district in northern Uganda, was selected by the Ugandan Ministry of Health for a pilot of the ADUNU program (Fig 1). Kitgum is located approximately 460 km north of Kampala, Uganda’s capital city. The population of Kitgum was estimated to be 226,700 in 2020 [22]. There are 11 government sub-country or higher level health centers in Kitgum district, which include a District Hospital, one health center IV, and nine health center IIIs. HCWs, Nurses and clinical officers, in these facilities who were interested in participating in the program and available on the day of training were eligible for RHD screening training under the ADUNU program. Onboarding of participating health care centers included district engagement that started nine months prior to HCW training. Training preparation included identification of facilities for training by the District Health Office (DHO), messaging about the training from the DHO office to the health facilities, and intake at each of these facilities to identify staff that qualified for participation.

Fig 1. Map of Uganda Showing ADUNU District Kitgum in Relation to the Uganda Heart Institute in Kampala.

Fig 1

Reprinted under a CC BY license, with permission from the Kitgum District Health Officer, original copyright 2025.

Training plan

The training plan for RHD screening had three components including initial training (didactic and hands-on), audit and feedback, and in-person booster sessions as needed for re-training. Two benchmarks, conditional and final certification, were used to assess whether HCWs reached a satisfactory level of screening competence.

For initial training, tablets pre-loaded with a set of ten training modules were delivered to participating clinics at least two weeks prior to in-person training. Each trainee was asked, but not required, to complete these modules to build background knowledge. This was followed by a 1-week in-person training, delivered by the UHI technical team. In-person sessions included interactive lectures and proctored hands-on practice screening. Trainees were taught to use the Lumify device (Philips Healthcare, Best, Netherlands) and focused on mastery of a three-step parasternal long axis (PLAX) protocol consisting of a two-dimensional interrogation of the mitral and aortic valves, color Doppler interrogation of the mitral valve, and color Doppler interrogation of the aortic valve. Interpretation criteria for a positive echocardiogram were practiced, including mitral regurgitation ≥ 2 cm, aortic regurgitation jet ≥ 1 cm, restricted mitral valve opening (identified by turbulent color Doppler inflow), pericardial effusion ≥ 1 cm, or qualitatively reduced systolic left ventricular function. To ensure clinical safety, positive studies (either from HCW or expert) were referred for confirmatory echocardiogram at a regional health center. The full outline of the training program can be found in S1 Fig.

After initial training, audit and feedback was provided through remote support. In brief, clinics uploaded all screening studies to a cloud-based repository (Tricefy, Trice Imaging, Del Mar, California, USA). A team of six cardiologists in the US and Uganda reviewed the echocardiograms, utilizing the same criteria to determine if studies were positive or negative [12]. Image quality was assessed by the American College of Emergency Physicians (ACEP) ultrasound image quality grading scale [23]. ACEP scores included: (1) no recognizable structures, no objective data can be gathered, (3) minimum criteria met for diagnosis, recognizable structures but with some technical or other flaws, or (5) minimal criteria met for diagnosis, all structures imaged with excellent image quality and diagnosis completely supported. Reviews were performed every two weeks with the results communicated back to trainees by the ADUNU district team to provide continuing education, including intermittent group review of missed cases.

Booster sessions were provided for trainees who continued to perform screening echocardiograms but had not yet completed training by 3 months. These in-person sessions were customized to the learner’s needs but included on-site (at the trainee’s home clinic) and off-site (RHD training center at the District Hospital) sessions to address gaps in knowledge and performance, with a heavy focus on bolstering recognition of positive studies.

Trainee evaluation

There were multiple opportunities for trainee evaluation. At the end of the 1-week in-person training, HCWs who attended at least 80% of training sessions and completed at least 10 independent scans during the training were assessed for conditional certification. Successful conditional certification included trainees completing 2 scans with direct observation of basic machine skills (turn on, set up for a study, hold probe correctly), correct patient positioning on the bed, and adequate image acquisition (could independently acquire three step PLAX protocol). Achieving conditional certification allowed trainees to perform independent RHD screening at their health facility, with audit and feedback oversight. If conditional certification was not achieved at the end of the first week, a customized plan was put into place to include additional mentorship from the ADUNU technical team and/or peer to peer mentoring at the facility. Repeated evaluations were available at later dates when the ADUNU technical team was conducting regular clinic site visits. Final certification was assessed on a rolling basis. Minimum criteria for final certification included completion of at least 100 independent scans, scanning for a minimum of 12 weeks, and correct identification of >90% screen positive scans for 2 consecutive weeks. Achieving final certification allowed health care workers to perform independent RHD screening at their facility, without the need for direct audit and feedback, although ongoing support remained available if needed.

Logic model iteration (Fig 2)

Fig 2. A logic model for planning and evaluation of the ADUNU Training Program for RHD Screening.

Fig 2

We used a logic model framework, a process tool for program planning, implementation, and evaluation, to illustrate the local program and its various components including inputs, activities, outputs, and outcomes [24,25]. The first author (P.W.) generated a logic model 15 months after program implementation using data of programmatic documents (described above) and assessed whether these components were aligned with the intended outcomes. The logic model was reviewed and revised through an iterative process with the remainder of the research team.

Outcomes and statistical analysis

The overall goal of this analysis was to evaluate if the ADUNU training program resulted in trained HCWs who were successful at integrating RHD screening into practice. We tabulated descriptive statistics to quantify resources, activities, and outputs of the ADUNU training program. Three primary outcomes were identified. First, we were interested in the percentage of HCWs who integrated screening into practice, defined as completion of an average of at least 20 screening studies per month. This was further broken down by participating facility. Second, we measured the percentage of HCWs who reached final certification, including the time it took for them to reach final certification and the number of screening studies completed prior to final certification. Finally, we looked at a sub-analysis of the percentage of HCWs that required a re-training (booster session) to achieve final certification.

We tabulated descriptive statistics for screening and agreement data. Statistical analysis was performed using RStudio (R version 4.5.2) [26]. We report the key findings from the local program document review in the logic model framework as inputs, activities, outputs, and outcomes.

Results and discussion

Resources

Two main categories of input were necessary for training: supplies/equipment and human resources, which includes quantified time as well as program knowledge, experience, and expertise. Supplies were either purchased (tablets, generators, and training workbooks) or provided in-kind (echo machines, training modules, and cloud-based image storage/transfer). Table 1 contains a comprehensive list with estimated values for in-kind inputs. Human resources for training included a two-person team of trainers from the RRCU and the district RHD focal person, a health care worker previously trained to provide comprehensive RHD care for the district. Training was supported in some phases by a remote core echocardiography lab and six remote expert echocardiography reviewers.

Table 1. Supply and Equipment Resources Investment for RHD Screening Training under the ADUNU Program.

Description Units ADUNU Cost Actual Cost
Echo Machines Lumify Probe (Philips Healthcare), $4500/probe 15 Probes In-kind $67,000
Tablets Samsung Galaxy S9, $349/tablet 16 $5584 $5584
Generator(s) Required during training to provide charging for devices on-site, $250/unit 2 $500 $500
Training Materials: Modules + Presentations Moodle (open source) software (free), PowerPoint (Microsoft) included on trainer computers (free) n/a $0 $0
Training Materials: Hard-copy workbooks Printing of hard-copy custom workbooks ($6.20/workbook) 65 $405 $405
Cloud-based Image Transfer Tricefy (Trice) cloud-based image management and documentation solution 1 In-kind $12,581

Activities

During the initial training week, 61 trainees spent an average of 26 hours each participating in didactic and hands-on scanning sessions (Table 2). The RRCU trainers and the RHD district focal person spent a combined 135 hours during each initial training week at each of the 11 sites, followed by an additional 40 hours/week providing ongoing audit and feedback. HCW remediation took place for those who were meeting their screening volume targets but not achieving final certification (seven to eleven months after initial training). There were 29 trainees who participated in these one-day retraining sessions, which included PowerPoint review of positive and missed positive echo clips and hands on image acquisition and interpretation. The cumulative cost of the initial training, audit and feedback, and remediation activities was $65,574.

Table 2. Human Resource Investment for RHD Screening Training under the ADUNU Program.

Description of Human Resources
RRCU Trainers 3 staff, 1 adult cardiologist, 2 senior research nurses ((≈19.20/hour*)
RHD Focal Person Fulltime MOH senior nurse RHD district coordinator (≈5.57/hour*)
Trainees Public health nurses, midwives, and clinical officers (≈2.92/hour*)
Remote Echo Readers 6 cardiologists/cardiology fellows, US pediatric cardiology median salary (≈$98.50/hour*)
Core Echo Lab Coordinator Research coordinator that cataloged studies coming in for reading, assigned studies to be read, and compiled and sent reports for local team action (≈$28.85/hour*)
HCW Training 1 week/health center, 6 hours of didactics dedicated to RHD screening, ≈ X hours of hands-on supervised scanning practice/trainee
RRCU Trainers 2 per training week, at health center ≈9 hours/day for 5 days, at 11 health centers 990 hours $19,008 $19,008
RHD Focal Person During training week, at health center ≈9 hours per day x 5 days 495 hours $2757 $2757
Trainees 61 trainees, each with 6 hours of didactics, ≈ 20 hours/scanning or observing scanning/week 1586 hours In-kind $4631
Audit + Feedback Health center upload to cloud, core echo lab coordinator, remote echo reader overread, went on for X weeks.
RRCU Trainers 1 in-district team member providing feedback to sites with in-person visits and WhatsApp reporting, approximately 20 hours/week for 52 weeks. 1040 hours $19,968 $19,968
RHD Focal Person 1 in-district team member providing feedback to sites with in-person visits and WhatsApp reporting, approximately 20 hours/week for 52 weeks. 1040 hours $19,968 $19,968
Remote Echo Readers Approximately 3 minutes per review and reporting x 6609 studies 202 hours In-Kind $19,927
HCW Remediation 6 retraining events, each 1 day in length, combination of on-site (at a healthcare center) and offsite at the District Hospital
RRCU Trainers 2 per training day, at health center ≈9 hours/day for 6 days 108 hours $2,074 $2,074
RHD Focal Person 1 per training day, at health center ≈9 hours/day for 6 days 54 hours $1,037 $1,037
Trainees 29 trainees, at health center ≈9 hours/day for 1 day 261 hours $762 $762

*Based on a 40-hour work week.

Abbreviations: HCW – Health Care Worker, RRCU – Rheumatic Heart Disease Research Collaboration in Uganda

Outputs derived from program resources and activities

In total, all 10 qualifying public facilities participated in training, including one health center IV and nine health center IIIs. Initial training was completed by 61 HCWs. Most HCWs (98%) attended at least 90% of the in-person didactic lectures. Conditional certification was granted to 58 (95%) HCWs at the completion of their initial training, indicating sufficient baseline image acquisition skills (Table 3).

Table 3. Outcomes for RHD Screening Training under the ADUNU Program.

Description
HCWs Participating in Initial Training Defined as those who started the initial training week 61 (Total N)
HCWs Reaching Conditional Certification Defined as successfully completing the initial training 58 (95.1%; 95% CI 86–98.9%)
58 (Total N)
HCWs Integrating Echo Screening into Practice Defined as ≥20/month from completion of initial training to final certification or study completion 23 (39.7%: 95% CI 28.1–52.5%)
HCWs Reaching Final Certification Criteria include ≥100 independent scans, scanning for ≥12 weeks, and correct identification of ≥90% screen positive scans for 2 consecutive weeks. 17 (29.3%; 95% CI 19.1–42.1%)
HCWs Continuing Screening After Final Certification Defined as ≥20/month from receipt of final certification to study completion 14 (93.3%; 95% CI 68.1–99.8%)*
Screening Echos Completed After Final Certification Echos performed after HCW achieved final certification 7,294

*2 HCWs reached final certification at the time of data analysis and were therefore not able to be assessed for continued screening, making this 14/15 HCWs. The lone HCW not screening ≥20/month from receipt of final certification to study completion was performing 19 scans/month.

CI = confidence interval

Audit and feedback and retraining.

Of the 10,232 echos performed during the audit and feedback period, 9,482 (93%) were successfully uploaded to the cloud for remote interpretation. The most common technical challenges included 477 (5%) studies that were not uploaded due to WIFI disruption and 273 (3%) studies that were deleted or not saved prior to image upload. The major areas of feedback included optimization of image acquisition (placement of color box over the correct valve, appropriate image depth, appropriate image 2D and color gain), troubleshooting of image upload/technical problems, and recognition of RHD positive scans.

Twenty-nine HCWs (54%) required and completed at least one remediation session. HCWs were eligible for remediation if they had been conditionally certified for at least three months and had performed at least 50 independent scans, but had not yet met final certification criteria. There were four additional HCWs who met criteria for remediation but missed the remediation due to illness, inability to leave their health center, or conflict with personal time off.

Outcomes derived from programmatic outputs

HCWs achieving RHD echo screening competency.

Of the HCWs who reached conditional certification, 29% (17/58) (29%) achieved mastery of the required set of competencies and received final certification. The median duration to achieve final certification was 6.9 months (IQR 5.0–8.2). Four HCWs reached final certification without the need for re-training, while 13 HCWs reached final certification after re-training. 67% (39/58) of HCWs were asked to stop screening after failing to meet a minimum number of practice scans over several months and the remaining two (3%) HCWs remained in training at the time of data collection. HCWs who achieved final certification continued to perform a median of 44 (IQR 22–58) screening echocardiograms per month through the last follow up (median 8 months IQR [8–10]).

Sensitivity, specificity, and image quality.

During the conditional certification period, 97% of echos with an expert overread were of adequate diagnostic quality (Table 4). HCWs achieved excellent image quality (ACEP 5) in 59% of studies, adequate image quality (ACEP 3) in 38%, and lack of diagnostic images (ACEP 1) in only 3%. Image quality improved from an average rating of 3.39 in the first 3 months to 4.06 in the last 3 months of data collection.

Table 4. Characteristics of all RHD Screening Studies.
Total RHD Screening Studies 17,927
 RHD Screen Positive 943 (5.3%)
Study Quality (total graded 6,528)
 Excellent – ACEP 5 3,839 (59%)
 Adequate – ACEP 3 2,495 (38%)
 Inadequate – ACEP 1 194 (3%)
Characteristics of Individuals Receiving Screening
 Median age (years) 18 years (IQR 12–27 years)
  Female 67%
Screener Sensitivity for RHD 60.8% (95% CI: 55.7–65.7%)
Screener Specificity for RHD 95.8% (95% CI: 95.2–96.3%)
Positive Predictive Value 50.6% (95% CI: 46–55.3%)
Negative Predictive Value 97.1% (95% CI: 96.7–97.6%)

The overall sensitivity and specificity of nurses during the conditional certification period, based on expert overread was 61% (95% CI: 55.7–65.7%) and 96% (95% CI: 95.2–96.3%), respectively (Table 4), with those receiving final certification achieving >90% sensitivity over at least 2 consecutive weeks. HCW training was very effective at teaching HCWs how to recognize moderate and severe RHD, as evidenced by 25/27 cases of moderate/severe RHD appropriately graded screen positive during the audit and feedback period.

HCWs integrating screening into practice.

Of those reaching conditional certification, 23 (40%, 95% CI 28.1–52.5%)) continued to integrate screening into practice (≥20 scans/month) over the course of the study period. One likely contributor to HCWs not integrating screening into practice was a planned annual provider rotation between healthcare centers in the district, which included 27 of the 58 trained HCWs (47%). This rotation, which occurred 6–11 months into RHD screening training, resulted in some facilities having no trained HCWs, some HCWs moving to facilities that did not offer screening (i.e., lower-level facilities, HCIIs). On-boarding processes for those transferred also resulted in 4–6 weeks where trained HCWs were not screening (Fig 1). An additional barrier was a single HCIII that was temporarily closed during the training period for 4 months. This facility had 2 trainees assigned, who were not able to continue their practice Fig 3.

Fig 3. Monthly screening variation in Kitgum District.

Fig 3

Early program impacts.

In total, 17,927 community members were screened under the ADUNU program during the 15 months included in this study. This includes 401 screening echos during the initial training, 10,232 screening echos during the audit and feedback period, and 7,294 screening echos by HCWs after achieving final certification. Of those screened, the median age was 18 years (IQR 12–27 years), with 67% being female (Table 3). Screening was positive in 5% of studies, generating 943 referrals for confirmatory diagnosis.

ADUNU impact and key lessons learned for future program iterations

Early success and impact.

Our evaluation of the ADUNU program’s training curriculum for RHD echocardiography screening 15 months following its implementation, revealed that the RHD echocardiography training within an existing public health system in sub-Saharan Africa is feasible and effective, but resource-intensive. Ultimately, 17 HCWs achieved final certification for RHD screening with most continuing to incorporate screening into their practice at the time of this analysis. While other large scale echocardiography screening studies have utilized task-shifting, our study is the first to critically evaluate the implementation of an RHD screening training program using a logic model lens [15,27,28]. Our study also adds to the growing regional East African literature regarding RHD screening programs [29]. Our analysis has revealed several key insights that highlight areas, which once refined, could further strengthen our training model and expand its utility to other RHD endemic global health settings.

Need for improved RHD sensitivity.

While most HCWs demonstrated technical competency in image acquisition within the first week and maintained high image quality throughout the study, there were notable gaps in screening accuracy in particular pertaining to recognizing positive cases. Sensitivity during the conditional certification period was 61%, which falls below the 67–84% sensitivity reported in prior studies of briefly trained non-expert providers and our own programmatic target of 90% [10,15,16]. Sensitivity must be improved as delayed diagnosis and enrollment in the appropriate care-based registry may allow for illness progression and worse health outcomes. Our data shows that sensitivity can be increased through intensive re-training, specifically focusing on identifying positive cases through frequent, repetitive pattern recognition practice of RHD positive screening echocardiograms. However, this has implications for costs and feasibility, which must be taken into consideration when developing the re-training program.

Need for decreased reliance on human resources.

ADUNU’s use of a remote audit-and-feedback approach during conditional certification encountered several challenges related to delays in gathering screening images, uploading them to the cloud server, and having them overread by the remote team of cardiologists, resulting in slower than anticipated feedback to trainees. Additionally, the overread burden for this remote team was extraordinarily high. Each cardiologist overread more than a thousand screening studies, a responsibility that would be difficult, if not impossible, to replicate with larger or expanded RHD screening programs in other endemic settings. Artificial intelligence (AI) has shown promise in correctly diagnosing RHD on portable echocardiography machines and may offer an alternative, although accurate recognition on handheld ultrasound machines and single view protocols, which were used in this study, is still in development [30].

While reliance on clinicians for training and retraining is common [28], the training and re-training burden on ADUNU’s was significant across the 15 months, (average time burden 40 hours per week), and even so, staff could not visit all 11 facilities frequently enough to provide consistent in-person guidance, further limiting support. Possible solutions include regular in-person booster sessions at a central training location, such as the District Hospital. However, this approach is resource-intensive and requires taking HCWs away from their daily duties. An alternative is utilizing AI to automate booster training and provide continuous education [31]. We are currently exploring innovative solutions such as leveraging large language models and just-in-time educational content delivered via WhatsApp to improve this training model, enabling more timely and consistent learning without the logistical constraints of in-person sessions.

Identification of early adopters/high performers.

The program also revealed that only a subset of HCWs continued to screen consistently, suggesting that both facility-level and individual-level factors likely influence adoption and performance. These factors may include available resources, organizational support, personal motivation, enjoyment of screening, and the perceived value of the screening program. Ongoing research aims to identify these key determinants, which could allow for more efficient use of training resources by identifying high-performing HCWs early in the process. Furthermore, recognizing high performers could facilitate peer mentorship, fostering a collaborative learning environment that boosts overall screening adoption and performance across facilities. Ultimately, understanding these adoption determinants will help refine the training model, making it more efficient, equitable, and impactful [32].

Training flexibility.

The rollout of the ADUNU program faced several unanticipated challenges, most notably the rotation of HCWs across facilities, which disrupted training continuity and left some facilities without adequately trained HCWs. While such a rotation system may not be common in other regions seeking to implement screening programs, it highlights the need for the innovative and automated solutions proposed above that are less reliant on in-person sessions. In the meantime, we have planned an annual training for both HCWs who did not reach final certification in the initial round but remain interested, as well as for new HCWs who have not yet received training. This approach will help maintain a consistent pipeline of trained HCWs and minimize disruptions in service delivery. Ultimately, if this approach scales across Uganda, embedding RHD screening into standard nursing education may be a more sustainable model [33].

Proposed modifications for next program iteration.

The current analysis is limited by the lack of long-term data. Research is underway to assess the program’s longer-term impact on district-level RHD case identification. Additionally, several modifications have been made to the training program based on our key insights. There is more frequent and repetitive HCW pattern recognition practice of positive RHD screening echocardiograms, with the understanding that increased experience and repetitions will increase sensitivity. We are leveraging individual HCW referral data (such as true and false positive scans at the confirmatory care clinic) to guide re-education instead of relying on remote audit-and-feedback to reduce the need for a cardiologist overread. And we are implementing tablet-based education that can be accessed offline at the facilities (S2 Fig) to mitigate the time burden on ADUNU staff. This model is currently being rolled out in a second district in Uganda, providing an opportunity to test these modifications aimed at improving screening uptake, sensitivity, and reducing training burdens. Prior to expanding at the regional and global level, we must create a more effective and streamlined training program. Further evaluation will be essential to understand the full impact of these changes as we continue to refine the training model.

Conclusion

The ADUNU training model for scaling up RHD screening has proven that integrating RHD screening into the Ugandan public health primary care system is both feasible and impactful, with high uptake observed in the first 15 months of the program. While the sensitivity is currently suboptimal, the future training program iteration is designed to improve disease recognition while also reducing the burden on human resources. With the 2024 World Health Organization guidelines now recommending routine RHD screening, the ADUNU model offers a promising blueprint for other countries seeking to implement or scale up screening services [8]. As nations move forward with the mandate for universal RHD screening, further refinement of the ADUNU training model will position it as a scalable, adaptable framework that can guide efforts to reduce the burden of rheumatic heart disease worldwide.

Key messages

What is already known on this topic

Echocardiography screening for RHD has gained support as a public health approach, but scale up of RHD screening services is complex, especially in resource-constrained settings.

What this study adds

We performed a logic model evaluation of the Accelerating Delivery of Rheumatic Heart Disease Prevention in Northern Uganda (ADUNU) Program, a novel RHD control program, 15 months after its implementation within the Ugandan public health care system. Our proposed training model for scaling up RHD echocardiography training within an existing public health system in sub-Saharan Africa is feasible and effective, but resource intensive.

How this study might affect research, practice, or policy

Our model is a scalable and adaptable framework that can guide efforts globally to reduce the burden of RHD.

Supporting information

S1 Fig. Training program outline.

(DOCX)

pone.0344012.s001.docx (23.4KB, docx)
S2 Fig. Revised training program education outline.

(DOCX)

pone.0344012.s002.docx (18.9KB, docx)

Abbreviations

ACEP

American College of Emergency Physicians

AI

Artificial intelligence

ADUNU

Accelerating Delivery of Rheumatic Heart Disease Prevention in Northern Uganda

CI

Confidence Intervals

DHO

District Health Office

HCIII

Health Center III

HCW

: Healthcare worker,

PLAX

: parasternal long axis,

RHD

: Rheumatic heart disease,

RRCU

: RHD Research Collaborative in Uganda,

UHI

: Ugandan Heart Institute,

WHF

– World Heart Federation.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

NIH Grant R01HL164615.

References

  • 1.Rwebembera J, Marangou J, Mwita JC, Mocumbi AO, Mota C, Okello E, et al. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease. Nat Rev Cardiol. 2024;21(4):250–63. doi: 10.1038/s41569-023-00940-9 [DOI] [PubMed] [Google Scholar]
  • 2.Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357(5):470–6. doi: 10.1056/NEJMoa065085 [DOI] [PubMed] [Google Scholar]
  • 3.Nascimento BR, Nunes MCP, Lopes ELV, Rezende VMLR, Landay T, Ribeiro ALP, et al. Rheumatic heart disease echocardiographic screening: Approaching practical and affordable solutions. Heart. 2016;102(9):658–64. doi: 10.1136/heartjnl-2015-308635 [DOI] [PubMed] [Google Scholar]
  • 4.Regmi PR, Pandey MR. Prevalence of rheumatic fever and rheumatic heart disease in school children of Kathmandu city. Indian Heart J. 1997;49(5):518–20. [PubMed] [Google Scholar]
  • 5.Grover A, Dhawan A, Iyengar SD, Anand IS, Wahi PL, Ganguly NK. Epidemiology of rheumatic fever and rheumatic heart disease in a rural community in northern India. Bull World Health Organ. 1993;71(1):59–66. [PMC free article] [PubMed] [Google Scholar]
  • 6.de Loizaga SR, Beaton AZ, Nascimento BR, Macedo FVB, Spolaor BCM, de Pádua LB, et al. Diagnosing rheumatic heart disease: where are we now and what are the challenges?. Expert Rev Cardiovasc Ther. 2021;19(9):777–86. doi: 10.1080/14779072.2021.1970531 [DOI] [PubMed] [Google Scholar]
  • 7.Beaton A, Okello E, Rwebembera J, Grobler A, Engelman D, Alepere J, et al. Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease. N Engl J Med. 2022;386(3):230–40. doi: 10.1056/NEJMoa2102074 [DOI] [PubMed] [Google Scholar]
  • 8.World Health Organization. WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease. Geneva; World Health Organization; 2024. [PubMed] [Google Scholar]
  • 9.Santos JPAD, Carmo GAL, Beaton AZ, Lourenço TV, Diamantino AC, Nunes CP, et al. Challenges for the Implementation of the First Large-Scale Rheumatic Heart Disease Screening Program in Brazil: The PROVAR Study Experience. Arq Bras Cardiol. 2017;108(4):370–4. doi: 10.5935/abc.20170047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mirabel M, Bacquelin R, Tafflet M, Robillard C, Huon B, Corsenac P, et al. Screening for Rheumatic Heart Disease. Circ: Cardiovascular Imaging. 2015;8(1). doi: 10.1161/circimaging.114.002324 [DOI] [PubMed] [Google Scholar]
  • 11.Godown J, Lu JC, Beaton A, Sable C, Mirembe G, Sanya R, et al. Handheld echocardiography versus auscultation for detection of rheumatic heart disease. Pediatrics. 2015;135(4):e939-44. doi: 10.1542/peds.2014-2774 [DOI] [PubMed] [Google Scholar]
  • 12.Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--An evidence-based guideline. Nat Rev Cardiol. 2012;9(5):297–309. doi: 10.1038/nrcardio.2012.7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Saxena A. Rheumatic heart disease screening by “point-of-care” echocardiography: an acceptable alternative in resource limited settings?. Transl Pediatr. 2015;4(3):210–3. doi: 10.3978/j.issn.2224-4336.2015.06.01 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ubels J, Sable C, Beaton AZ, Nunes MCP, Oliveira KKB, Rabelo LC, et al. Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil. Glob Heart. 2020;15(1):18. doi: 10.5334/gh.529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ploutz M, Lu JC, Scheel J, Webb C, Ensing GJ, Aliku T, et al. Handheld echocardiographic screening for rheumatic heart disease by non-experts. Heart. 2016;102(1):35–9. doi: 10.1136/heartjnl-2015-308236 [DOI] [PubMed] [Google Scholar]
  • 16.Colquhoun SM, Carapetis JR, Kado JH, Reeves BM, Remenyi B, May W, et al. Pilot study of nurse-led rheumatic heart disease echocardiography screening in Fiji--a novel approach in a resource-poor setting. Cardiol Young. 2013;23(4):546–52. doi: 10.1017/S1047951112001321 [DOI] [PubMed] [Google Scholar]
  • 17.Engelman D, Kado JH, Reményi B, Colquhoun SM, Carapetis JR, Wilson NJ, et al. Screening for rheumatic heart disease: quality and agreement of focused cardiac ultrasound by briefly trained health workers. BMC Cardiovasc Disord. 2016;16:30. doi: 10.1186/s12872-016-0205-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lamichhane P, Patel F, Al Mefleh R, Mohamed Gasimelseed SY, Ala A, Gawad G, et al. Detection and management of latent rheumatic heart disease: A narrative review. Ann Med Surg (Lond). 2023;85(12):6048–56. doi: 10.1097/MS9.0000000000001402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nakagaayi D, Pulle J, Otim I, Akiya OC, Otto OH, Danforth K, et al. A decentralized delivery program for rheumatic heart disease treatment and prevention in Uganda. Nat Med. 2024;30(1):12–3. doi: 10.1038/s41591-023-02646-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kaplan SA, Garrett KE. The use of logic models by community-based initiatives. Evaluation and Program Planning. 2005;28(2):167–72. doi: 10.1016/j.evalprogplan.2004.09.002 [DOI] [Google Scholar]
  • 21.Millar A, Simeone RS, Carnevale JT. Logic models: a systems tool for performance management. Evaluation and Program Planning. 2001;24(1):73–81. doi: 10.1016/s0149-7189(00)00048-3 [DOI] [Google Scholar]
  • 22.Ugandan Bureau of Statistics. Ugandan Bureau of Statistics. https://www.ubos.org/explore-statistics/20/. Accessed 2024 May 7.
  • 23.Liu R, Blaivas M, Moore C, Sivitz AB, Flannigan M, Tirado A. Emergency Ultrasound Standard Reporting Guidelines. 2018. https://www.acep.org/siteassets/uploads/uploaded-files/acep/clinical-and-practice-management/policy-statements/information-papers/emergency-ultrasound-standard-reporting-guidelines---2018.pdf
  • 24.Kellogg Foundation WK. Logic Model Development Guide. Battle Creek, MI: W K Kellogg Foundation. 2001. [Google Scholar]
  • 25.Savaya R, Waysman M. The logic model: A tool for incorporating theory in development and evaluation of programs. Administration in Social Work. 2005;29(2):85–103. [Google Scholar]
  • 26.R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. 2023. [Google Scholar]
  • 27.Nascimento BR, Nascimento LRC, Souza LF, Carvalho WA, Silva EN, Rossi M. Echocardiographic prevalence of rheumatic heart disease in low-income Brazilian schoolchildren. Int J Cardiol. 2016;203:347–52.26539954 [Google Scholar]
  • 28.Harris A. Echo workforce development in the Fiji Islands. Australas J Ultrasound Med. 2020;23(1):30–2. doi: 10.1002/ajum.12197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ahmed Abdi I, Karataş M, Öcal L, Abdirahman Ahmed S, Sheikh Hassan M, Atilla K, et al. Pattern of rheumatic heart disease among patients attending at a tertiary care hospital in Somalia: first report from Somalia. Am J Cardiovasc Dis. 2023;13(5):345–53. [PMC free article] [PubMed] [Google Scholar]
  • 30.Brown K, Roshanitabrizi P, Rwebembera J, Okello E, Beaton A, Linguraru MG, et al. Using Artificial Intelligence for Rheumatic Heart Disease Detection by Echocardiography: Focus on Mitral Regurgitation. J Am Heart Assoc. 2024;13(2):e031257. doi: 10.1161/JAHA.123.031257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Narayanan S, Ramakrishnan R, Durairaj E, Das A. Artificial Intelligence Revolutionizing the Field of Medical Education. Cureus. 2023;15(11):e49604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76. doi: 10.1007/s10488-010-0319-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.World Health Organization. Increasing access to health workers in remote and rural areas through improved retention: global policy recommendations. Geneva: WHO. 2010. [PubMed]

Decision Letter 0

Rano Piryani

9 Nov 2025

Dear Dr. Warren,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

You have to revise the article in the light of comments of both reviewers.

==============================

Please submit your revised manuscript by Dec 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols ..

We look forward to receiving your revised manuscript.

Kind regards,

Rano Mal Piryani, MBBS, MCPS, DTCD, MD, Fellowship in Med Education

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.  When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following financial disclosure:

NIH Grant R01HL164615

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. Please amend your authorship list in your manuscript file to include author Paul Warren.

6. Please amend the manuscript submission data (via Edit Submission) to include author Paul W Warren.

7. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

8. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

9. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

10. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments :

Dear editor

I do agree with comments of both

Authors have to do minor revision in the lights of comments of both reviewers.

Regards

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: This manuscript addresses a highly relevant and timely topic: the feasibility of scaling up rheumatic heart disease (RHD) screening training within the public health system in Uganda. The work is ambitious, methodologically sound, and provides valuable lessons for other low-resource, high-prevalence settings. I believe this paper deserves publication after revisions. Below, I provide detailed comments to help strengthen the manuscript.

Reviewer #2: The topic of this manuscript is highly relevant; screening for RHD is essential but is faced with low resources in many “endemic” areas. This manuscript addresses the solution to have a cost-effective scale fulfilling this gap. Generally, the manuscript is well organized, relevant, clearly written, and well supported by extensive quantitative and qualitative data. One notable strength is the use of a logic model to frame program evaluation, which helps to align implementation activities with desired results.

I have a few items that need to be clarified:

The improvement in screening sensitivity after retraining is encouraging, but you can claim that the experience of the health workers and the number of cases they handled added to this improvement. Also, I would recommend a discussion about ways of expanding the program and how it could fit into the national health system and if it may fit for use in other countries. The authors should also address the lack of long-term patient outcomes as study limitations.

Please, explain the abbreviations when used for the first time. The authors should have the text checked for small language errors and spacing.

best of luck.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy .-->

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Attachment

Submitted filename: RHD UGANDA REVEIW.docx

pone.0344012.s003.docx (15.7KB, docx)
PLoS One. 2026 Mar 30;21(3):e0344012. doi: 10.1371/journal.pone.0344012.r002

Author response to Decision Letter 1


7 Dec 2025

We thank the reviewers and editor for their comments which we have addressed, and which we believe improves the manuscript. Please find attached in our uploaded documents our detailed response to each comment (which is easier to review than the below responses):

Reviewer #1: This manuscript addresses a highly relevant and timely topic: the feasibility of scaling up rheumatic heart disease (RHD) screening training within the public health system in Uganda. The work is ambitious, methodologically sound, and provides valuable lessons for other low-resource, high-prevalence settings. I believe this paper deserves publication after revisions. Below, I provide detailed comments to help strengthen the manuscript.

This is an important manuscript on rheumatic heart disease (RHD) screening training in Uganda. Its an ambitious and timely work that addresses a major public health gap in Sub-Saharan Africa. The study is well-structured, with clear methodology and valuable findings. I believe this paper deserves publication, provided the following issues are carefully addressed:

Major Points for Improvement

1. Tables and Data Presentation

Several tables are overloaded with details, which may reduce readability. Please simplify by separating inputs/resources from outcomes or moving highly technical cost details to supplementary material.

We have separated the human and equipment resources into separate tables (Tables 1 and 2). The outcomes data is presented by itself in Table 3.

Ensure that percentages and denominators are always clear (e.g., specify the “n” for conditional vs final certification groups in tables).

We have more clearly specified the denominators in Table 3 and Table 4.

2. Results and Statistics

The results are descriptive, which is acceptable, but the statistical presentation can be strengthened. Confidence intervals should be added for sensitivity/specificity estimates and for major proportions (e.g., final certification rates).

We have added confidence intervals to the sensitivity/specificity estimates and positive and negative predictive values to strengthen the statistical presentation (shown in Table 4). Confidence intervals have also been added for certification rates (Table 3). Statistical analysis was performed using RStudio (methods section updated).

Consider logistic regression or stratified analysis to identify predictors of successful certification and sustained practice. This would add depth and highlight determinants of program success.

We strongly agree with the reviewer that identification of successful certification and sustained practice is important. However, we feel it is outside the scope of this current manuscript. We highlight that the identification of key determinants is undergoing in other research projects in our “Identification of early adopters/high performers” section (lines 306-310).

3. Discussion

o The discussion is somewhat repetitive in places. Please sharpen the focus by directly contrasting your findings with other large-scale RHD screening experiences (e.g., Fiji, Brazil PROVAR, etc.).

We made the discussion more concise while also highlighting that in comparison to other large scale RHD screening training programs, our study was one of the first to critically evaluate the implementation process itself, which provided us with key insights that once improved upon will result in a more effective and scalable RHD screening program.

o Expand on the implications of the low sensitivity (59%), and propose concrete strategies for improving early detection (e.g., booster training, AI-assisted screening, embedding RHD into standard nursing curricula).

We expanded upon the implications of the low sensitivity (lines 256-260). We propose frequent and repetitive practice recognizing RHD positive screening echocardiograms as the best way to improve sensitivity. We have added our revised training program as Supplementary Information Figure 2 (line 318) as it shows the increased pattern recognition practice that is required during the initial training (1b) and independent scanning (2a) periods.

o Please include regional context. There are now reports emerging from Horn of Africa, which provide valuable complementary evidence. We recommend citing:

� Abdi IA, Karataş M, Öcal L, Ahmed SA, Hassan MS, Atilla K, Mohomud MF. Pattern of rheumatic heart disease among patients attending at a tertiary care hospital in Somalia: first report from Somalia. Am J Cardiovasc Dis. 2023 Oct 15;13(5):345.

� Abdi IA, Karataş M, Öcal L, Elmi Abdi A, Farah Yusuf Mohamud M. Retrospective analysis of left ventricular thrombus among heart failure patients with reduced ejection fraction at a single tertiary care hospital in Somalia. Open Access Emerg Med. 2022;14:591–7.

o Including these will help frame Uganda’s experience as part of a broader East African movement toward locally generated data and scalable solutions.

We added the citation to the first paragraph of the discussion, highlighting the growing body of regional East African literature characterizing RHD and RHD training programs.

4. Conclusion

o The conclusion should be more concise and action-oriented. Currently, it repeats parts of the discussion. Instead, emphasize three key take-home messages:

1. RHD screening training is feasible in public health systems.

2. Sensitivity remains suboptimal and requires iterative training/innovation.

3. The model is scalable and should inform regional/global policies.

We have modified the conclusion to be more concise and include these three key take-home messages.

Despite these areas for improvement, I want to emphasize that this is a very strong and much-needed paper. With sharper presentation of the data, strengthened analysis, and improved discussion, this manuscript will make an important contribution to the global RHD literature. If the above revisions are approached carefully, I am confident the paper will be accepted for publication.

We thank the reviewer for their helpful suggestions that have improved the manuscript.

Reviewer #2:

The topic of this manuscript is highly relevant; screening for RHD is essential but is faced with low resources in many “endemic” areas. This manuscript addresses the solution to have a cost-effective scale fulfilling this gap. Generally, the manuscript is well organized, relevant, clearly written, and well supported by extensive quantitative and qualitative data. One notable strength is the use of a logic model to frame program evaluation, which helps to align implementation activities with desired results.

I have a few items that need to be clarified:

The improvement in screening sensitivity after retraining is encouraging, but you can claim that the experience of the health workers and the number of cases they handled added to this improvement. Also, I would recommend a discussion about ways of expanding the program and how it could fit into the national health system and if it may fit for use in other countries. The authors should also address the lack of long-term patient outcomes as study limitations.

We agree with the reviewer that increased health care worker experience was complimentary to the re-training sessions, in improving their screening sensitivity. We have added a statement acknowledging the important role of increased healthcare worker experience and repetitions to increase sensitivity in our “Proposed modifications for the next program iteration” section (lines 329-331).

We are currently expanding the program to a second district in northern Uganda. For the model to fit into the national health system in Uganda and other countries, we must first improve the sensitivity and reduce the burden on human resources. We have specified this in our “Proposed modifications for the next program iteration” section (lines 339-343).

We have added a statement acknowledging the limitation of the current analysis due to lack of long-term data (line 327).

Please, explain the abbreviations when used for the first time. The authors should have the text checked for small language errors and spacing.

best of luck.

We have ensured that all abbreviations are explained with the first use and that language/spacing errors are eliminated.

Clarifications for the Editor

The correct grant identification is: R01HL1646150. This is what is listed in the manuscript file. We have added the requested statement regarding role of the funder to the funding statement on the title page.

Paul W Warren is listed as an author in the manuscript file and author submission form.

Captions have been uploaded for the supporting information files at the end of the manuscript.

Attachment

Submitted filename: Response to reviewers.docx

pone.0344012.s005.docx (21.9KB, docx)

Decision Letter 1

Rano Piryani

15 Feb 2026

Evaluation of a Training Program for Rheumatic Heart Disease Screening Integrated into the Public Health System in Uganda

PONE-D-25-39629R1

Dear Dr. Warren,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support ..

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Rano Mal Piryani, MBBS, MCPS, DTCD, MD, Fellowship in Med Education

Academic Editor

PLOS One

Additional Editor Comments (optional):

Dear Authors

Greetings

I appreciate that you have well responded to reviewer' comments point-wise.

With best regards

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The authors have addressed all previous comments, and the manuscript has been clearly improved. I have no further comments and consider it suitable for publication.

Reviewer #2: The authors have adequately addressed the comments, and I recommend acceptance of the manuscript in its revised form. Good luck

**********

what does this mean? ). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy .-->

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Rano Piryani

PONE-D-25-39629R1

PLOS One

Dear Dr. Warren,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Rano Mal Piryani

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Training program outline.

    (DOCX)

    pone.0344012.s001.docx (23.4KB, docx)
    S2 Fig. Revised training program education outline.

    (DOCX)

    pone.0344012.s002.docx (18.9KB, docx)
    Attachment

    Submitted filename: RHD UGANDA REVEIW.docx

    pone.0344012.s003.docx (15.7KB, docx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0344012.s005.docx (21.9KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES